Prognostic risk factors for failure of trabeculectomy with mitomycin C after vitrectomy

Jpn J Ophthalmol. 2012 Sep;56(5):464-9. doi: 10.1007/s10384-012-0171-2. Epub 2012 Aug 2.

Abstract

Purpose: To evaluate the prognostic risk factors for failure of trabeculectomy with mitomycin C (MMC) in vitrectomized eyes.

Methods: Retrospective cohort study. We reviewed the medical records of 116 patients (116 eyes) treated at Kumamoto University Hospital. The primary endpoints were persistent intraocular pressure of >21 mmHg, deterioration of visual acuity to no light perception, or additional glaucoma procedures. Multivariable analysis was performed with the Cox proportional hazards model.

Results: The mean follow-up period was 36.5 months (range, 0.5-134.1 months). The probability of success 1 year after trabeculectomy was 55.1 %, 2 years after was 45.3 %, and 3 years after was 43.1 %. The multivariable model showed that higher preoperative intraocular pressure (IOP) [relative risk (RR), 1.05/mmHg; P = 0.0077] and neovascular glaucoma (NVG) (RR, 1.88; P = 0.049) were prognostic factors for surgical failure.

Conclusions: The prognostic factors for surgical failure of trabeculectomy with MMC in vitrectomized eyes are a higher preoperative IOP and NVG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alkylating Agents / administration & dosage*
  • Combined Modality Therapy
  • Female
  • Glaucoma / diagnosis
  • Glaucoma / surgery*
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage*
  • Prognosis
  • Retinal Diseases / surgery
  • Retrospective Studies
  • Risk Factors
  • Tonometry, Ocular
  • Trabeculectomy*
  • Treatment Failure
  • Vitrectomy*
  • Young Adult

Substances

  • Alkylating Agents
  • Mitomycin